Legionnaires’ disease
Upcoming SlideShare
Loading in...5
×
 

Legionnaires’ disease

on

  • 2,115 views

Legionnaires’ disease

Legionnaires’ disease

Statistics

Views

Total Views
2,115
Views on SlideShare
2,089
Embed Views
26

Actions

Likes
3
Downloads
99
Comments
0

1 Embed 26

https://fiu.blackboard.com 26

Accessibility

Categories

Upload Details

Uploaded via as Microsoft PowerPoint

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

Legionnaires’ disease Legionnaires’ disease Presentation Transcript

  • LEGIONNAIRES’ DISEASE Dr.T.V.Rao MDDR.T.V.RAO MD 1
  • LEGIONELLOSIS A BACTERIAL INFECTION • Legionellosis is caused by gram- negative bacteria of the genus Legionella. • Legionellosis is a potentially fatal infectious disease caused by gram negative, aerobic bacteria belonging to the genus Legionella.] Over 90% of Legionellosis cases are caused by Legionella pneumophila, a ubiquitous aquatic organism that thrives in temperatures between 25 and 45 °C (77 and 113 °F), with an optimum temperature of 35 °CDR.T.V.RAO MD 2
  • SCIENTIFIC BEGINNING OF LEGIONNAIRES DISEASE• Legionnaires disease acquired its name in July 1976 when an outbreak of pneumonia occurred among people attending a convention of the American Legion at the Bellevue-Stratford Hotel in Philadelphia. On January 18, 1977 the causative agent was identified as a previously unknown strain of bacteria, subsequently named Legionella.DR.T.V.RAO MD 3
  • BACTERIOLOGY – LEGIONARIES DISEASE• A thin and flagellated gram- negative bacterium.• Non-capsulated rod-like bacteria.• Dot/Icm secretion system to inject large numbers of protein effectors into the host cells.• Pseudopod acts as a phagocytosis.• Incubation period: two to ten days.DR.T.V.RAO MD 4
  • EPIDEMIOLOGY OF LEGIONELLOSIS• Legionellae are ubiquitous worldwide. Most cases of Legionellosis are caused by Legionella pneumophila. Disease occurs after exposure to aquatic settings that promote bacterial growth—the aquatic environment is somewhat stagnant, the water is warm (77°F–108°F [25°C–42°C]), and the water must be aerosolized so that the bacteria can be inhaled into the lungs. These 3 conditions are met almost exclusively in developed or industrialized settings. Disease does not occur in association with natural settings such as waterfalls, lakes, or streams.DR.T.V.RAO MD 5
  • BREEDING OF LEGIONARIES DISEASE• The bacteria grow best in warm water, like the kind found in hot tubs, cooling towers, hot water tanks, large plumbing systems, or parts of the air-conditioning systems of large buildings. Indoor ornamental fountains have been confirmed as a cause of Legionnaires disease outbreaks, in which submerged lighting as a heat source was attributed to the outbreak in all documented casesDR.T.V.RAO MD 6
  • HOW THE LEGIONELLA THRIVE• Legionella thrive in man-made aquatic environments where the water temperature is higher than ambient temperature: whirlpool spas, cooling towers (air- conditioning units from large buildings), water used for drinking and bathing, water fountains, humidifiers, ice machines, and vegetable misters, etc. In fact, most cases of Legionellosis can be traced to using such systems. It is a major concern for health professionals and construction and water systems maintenance workers.DR.T.V.RAO MD 7
  • WHO ARE AT RISK• Opportunistic Disease: underlying illness/weak immune system.• Nosocomial infections are major concerns.• Middle-aged, elderly, COPD, smokers and other genetic susceptible patients are primary targets.DR.T.V.RAO MD 8
  • TRANSMISSION OF LEGIONELLA • L. pneumophila is NOT spread by human-human interaction. • Mist or vapour contaminated with the bacteria. • Warm stagnant water (90- 122 F) in complex systems is ideal.DR.T.V.RAO MD 9
  • HOW BACTERIUM THRIVE • Interest in this bacterium stems from its ability to manipulate host cell vesicular- trafficking pathways and establish a membrane-bound replication vacuole, making it model for intracellular or, more specifically,DR.T.V.RAO MD intravacuolar pathogens 10
  • DR.T.V.RAO MD 11
  • COMPLEX MECHANISMS IN LEGIONELLA INFECTIONDR.T.V.RAO MD 12
  • CLINICAL OBSERVATIONS Wide age distribution Very high fever Diarrhoea Hepatorenal dysfunction Raised troponin T Often looked disproportionally well Sudden deterioration common
  • CLINICAL PRESENTATIONS• Early Symptoms• Malaise, muscle aches, lethargy and slight headaches.• High Fever, non-productive cough, abdominal pain, diarrheal.• Late Symptoms• Extreme lethargy, comatose state• Impaired kidney and liver functioning• Nervous System disordersDR.T.V.RAO MD 14
  • CLINICAL PRESENTATIONS OF LEGIONNAIRES DISEASE• Legionnaires’ disease typically presents with pneumonia, which usually requires hospitalization and can be fatal in 10%– 15% of cases. Symptom onset occurs 2–14 days after exposure. In outbreak settings, <5% of people exposed to the source of the outbreak develop Legionnaires’ disease.DR.T.V.RAO MD 15
  • PONTIAC FEVER• Pontiac fever is milder than Legionnaires’ disease and presents as an influenza like illness, with fever, headache, and myalgias, but no signs of pneumonia. Pontiac fever can affect healthy people, as well as those with underlying illnesses, and symptoms occur within 72 hours of exposure. Most patients fully recover. Up to 95% of people exposed in outbreak settings can develop symptoms of Pontiac feverDR.T.V.RAO MD 16
  • LABORATORY DIAGNOSIS OF LEGIONELLA INFECTIONUrinary antigen testingSerologyCulture
  • WHO SHOULD BE TESTED FOR LEGIONNAIRES DISEASE? IDSA GUIDELINES• Hospitalized patients with enigmatic pneumonia• Patients with enigmatic pneumonia sufficiently severe to require care in the ICU• Compromised host with pneumonia• Patients with pneumonia in the setting of a Legionellosis outbreak• Patients who fail to respond to treatment to a ß-lactam or cephalosporin• Patients with a travel history [Patients that have traveled away from their home within two weeks before the onset of illness.]• Patients suspected of nosocomial pneumonia with unknown etiologyDR.T.V.RAO MD 18
  • DIAGNOSIS• Urinary Antigen Test• The serogroups of Legionella often times overlap with other immunocompromised diseases.• Culture • Lung biopsy, respiratory secretions, sputum • Less preferable techniqueDR.T.V.RAO MD 19
  • DIAGNOSIS• Isolation of Legionella from respiratory secretions, lung tissue, pleural fluid, or a normally sterile site is an important method for diagnosis of Legionnaires’ disease. Clinical isolates are often necessary to interpret the findings of an environmental investigation. Because of differences in mechanism of disease, Legionella cannot be isolated in people who have Pontiac fever.DR.T.V.RAO MD 20
  • CULTURING FOR LEGIONELLA• The culture method remains the "gold standard" for detecting Legionella from environmental sources. This technique, , requires up to 10 days to complete, precious time that could be used to pinpoint Legionella sources and prevent additional exposures.DR.T.V.RAO MD 21
  • PCR IN DIAGNOSIS OF LEGIONELLA INFECTION• Another Legionella detection method is polymerase chain reaction (PCR), a molecular technique that offers a very sensitive method and only requires a few hours to complete. The PCR method provides an extremely powerful screening tool for the rapid Legionella detection in environmental samples, although it doesnt distinguish between living and dead cells. But unless the environment has been recently altered, such as with a biocide application, moderate to high populations of Legionella detected by PCR are usually indicative of an existing or potential future problem.DR.T.V.RAO MD 22
  • DIAGNOSIS• The most used diagnostic method is the Legionella urinary antigen assay. However, the assay can only detect L. pneumophila serogroups 1, the most common cause of Legionellosis. Paired serology showing a 4-fold rise in antibody titer between acute- and convalescent-phase specimens confirms the diagnosis. A single antibody titer of any level is not diagnostic of legionellosis.DR.T.V.RAO MD 23
  • TREATMENT OF LEGIONELLOSIS• There is no vaccine for Legionellosis, and antibiotic prophylaxis is not effective. Travellers at increased risk for infection, such as the elderly or those with immunocompromising conditions such as cancer or diabetes, may choose to avoid high-risk areas, such as whirlpool spas. If exposure cannot be avoided, travelers should be advised to seek medical attention promptly if they develop symptoms of Legionnaires’ disease or Pontiac fever.DR.T.V.RAO MD 24
  • AN EFFECTIVE ANTIBIOTIC TREATMENT IS ESSENTIAL• Wide-range antibiotics to treat pneumonia• Fluoroquinolones (levofloxacin, Moxifloxacin)• Macrolides (azithromycin)• Mechanism• Quinolones: DNA gyrase inhibitors• Macrolides: binds to 50S subunit of ribosomesDR.T.V.RAO MD 25
  • PREVENTION OF LEGIONELLAS• Regularly maintain and clean cooling towers and evaporative condensers to prevent growth of Legionnaires’ disease Bacteria (LDB). This should include twice-yearly cleaning and periodic use of chlorine or other effective biocide.• Maintain domestic water heaters at 60°C (140°F). The temperature of the water should be 50°C (122°F) or higher at the faucet.• Avoid conditions that allow water to stagnate. Large water- storage tanks exposed to sunlight can produce warm conditions favourable to high levels of LDB. Frequent flushing of unused water lines will help alleviate stagnation.DR.T.V.RAO MD 26
  • MEASURES TO TRAVELLERS• There is no vaccine for Legionellosis, and antibiotic prophylaxis is not effective. Travellers at increased risk for infection, such as the elderly or those with immunocompromising conditions such as cancer or diabetes, may choose to avoid high-risk areas, such as whirlpool spas. If exposure cannot be avoided, travellers should be advised to seek medical attention promptly if they develop symptoms of Legionnaires’ disease or Pontiac fever.DR.T.V.RAO MD 27
  • • Programme created by Dr.T.V.Rao MD for Medical and Health Care Workers in the Developing World • Email • doctortvrao@gmail.comDR.T.V.RAO MD 28